Ftse Mib
34.160,97
1,25%
DAX
19.984,32
0,74%
S&P 500
5.970,84
-1,11%
NASDAQ
19.722,03
-1,49%
Bitcoin
93.772,81
-1,44%
Pepperstone
Advertisement
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Canada TSXV Sirona Biochem Corp (SBM) Sirona Biochem Corp (SBM) Notizie

SBM

Sirona Biochem (SBM)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:TSXV:SBM
DataOraFonteTitoloSimboloCompagnia
25/10/202304:58PR Newswire (Canada)TSX Venture Exchange Stock Maintenance BulletinsTSXV:SBMSirona Biochem Corp
20/12/202109:00PR Newswire (Canada)Sirona Biochem Antiviral Compounds to be Tested Against SARS-CoV-2 by Top US Testing FacilityTSXV:SBMSirona Biochem Corp
16/12/202109:00PR Newswire (Canada)Sirona Biochem Announces Engagement of Pullan Consulting to Close Optimal Deal for TFC-1067TSXV:SBMSirona Biochem Corp
13/12/202115:00PR Newswire (Canada)Sirona Biochem Provides Update on SGLT2 Inhibitor for Type 2 Diabetes in ChinaTSXV:SBMSirona Biochem Corp
10/11/202120:48PR Newswire (Canada)Sirona Biochem Announces 2021 Annual Meeting Results: Shareholders Approve All Resolutions With Majority VoteTSXV:SBMSirona Biochem Corp
12/10/202115:00PR Newswire (Canada)/R E P E A T -- Sirona Biochem: Investing News Network Interview with CEO, Dr. Howard Verrico/TSXV:SBMSirona Biochem Corp
12/10/202109:00PR Newswire (Canada)Sirona Biochem: Investing News Network Interview with CEO, Dr. Howard VerricoTSXV:SBMSirona Biochem Corp
06/10/202115:00PR Newswire (Canada)/R E P E A T -- Sirona Biochem Announces Advancement of TFC-1067/TSXV:SBMSirona Biochem Corp
06/10/202109:00PR Newswire (Canada)Sirona Biochem Announces Advancement of TFC-1067TSXV:SBMSirona Biochem Corp
22/09/202115:00PR Newswire (Canada)/R E P E A T -- Sirona Biochem Announces Discovery of Anti-Cellulite Activity in Compounds/TSXV:SBMSirona Biochem Corp
22/09/202109:00PR Newswire (Canada)Sirona Biochem Announces Discovery of Anti-Cellulite Activity in CompoundsTSXV:SBMSirona Biochem Corp
30/06/202115:00PR Newswire (Canada)/R E P E A T -- Sirona Biochem CEO Quarterly Update Q2 2021/TSXV:SBMSirona Biochem Corp
30/06/202109:00PR Newswire (Canada)Sirona Biochem CEO Quarterly Update Q2 2021TSXV:SBMSirona Biochem Corp
31/03/202115:00PR Newswire (Canada)/R E P E A T -- Sirona Biochem Reports Excellent Results in New Clinical Study on TFC-1067/TSXV:SBMSirona Biochem Corp
31/03/202109:00PR Newswire (Canada)Sirona Biochem Reports Excellent Results in New Clinical Study on TFC-1067TSXV:SBMSirona Biochem Corp
10/03/202115:00PR Newswire (Canada)/R E P E A T -- Sirona Biochem Announces Launch of First Commercial Product Containing TFC-1067/TSXV:SBMSirona Biochem Corp
10/03/202109:00PR Newswire (Canada)Sirona Biochem Announces Launch of First Commercial Product Containing TFC-1067TSXV:SBMSirona Biochem Corp
24/02/202115:00PR Newswire (Canada)/R E P E A T -- Sirona Biochem CEO Quarterly Update Q1 2021/TSXV:SBMSirona Biochem Corp
24/02/202109:00PR Newswire (Canada)Sirona Biochem CEO Quarterly Update Q1 2021TSXV:SBMSirona Biochem Corp
04/02/202100:00PR Newswire (Canada)Sirona Biochem Announces Grant of Stock OptionsTSXV:SBMSirona Biochem Corp
15/12/202012:05PR Newswire (Canada)Sirona Biochem Signs Agreement with Luxembourg-based CURE Intelligence for Social Media and Communications SupportTSXV:SBMSirona Biochem Corp
30/11/202015:00PR Newswire (Canada)/R E P E A T -- Sirona Biochem Releases CEO Letter to Shareholders/TSXV:SBMSirona Biochem Corp
30/11/202009:00PR Newswire (Canada)Sirona Biochem Releases CEO Letter to ShareholdersTSXV:SBMSirona Biochem Corp
26/10/202014:00PR Newswire (Canada)/R E P E A T -- Sirona Biochem Announces Acceptance of Clinical Study for TFC-1067 in the Journal of Cosmetic Dermatology/TSXV:SBMSirona Biochem Corp
26/10/202008:00PR Newswire (Canada)Sirona Biochem Announces Acceptance of Clinical Study for TFC-1067 in the Journal of Cosmetic DermatologyTSXV:SBMSirona Biochem Corp
13/10/202015:00PR Newswire (Canada)/R E P E A T -- Sirona Biochem Signs Agreement with Global Pharmaceutical Company for Clinical Trial of its Novel Skincare Co...TSXV:SBMSirona Biochem Corp
13/10/202009:00PR Newswire (Canada)Sirona Biochem Signs Agreement with Global Pharmaceutical Company for Clinical Trial of its Novel Skincare Compound TFC-1067TSXV:SBMSirona Biochem Corp
09/09/202015:00PR Newswire (Canada)/R E P E A T -- Sirona Biochem Contracts WuXi AppTec for Large-Scale Manufacturing of TFC-1067/TSXV:SBMSirona Biochem Corp
09/09/202009:00PR Newswire (Canada)Sirona Biochem Contracts WuXi AppTec for Large-Scale Manufacturing of TFC-1067TSXV:SBMSirona Biochem Corp
16/06/202015:00PR Newswire (Canada)/R E P E A T -- Sirona Biochem Ships First Batch of TFC-1067 to Rodan + Fields/TSXV:SBMSirona Biochem Corp
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:TSXV:SBM

La tua Cronologia

BIT
UCG
Unicredit
BIT
ISP
Intesa Sanpaolo
BIT
ENI
Eni
BIT
STLAM
Stellantis NV
BIT
ENEL
Enel
BIT
STMMI
ST Microelectronics
BIT
RACE
Ferrari NV
BIT
TIT
Telecom Italia
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
SRG
Snam
BIT
BPE
Bper Banca
BIT
BAMI
Banco BPM
BIT
SPM
Saipem
BIT
LDO
Leonardo
BIT
PRY
Prysmian
BIT
TEN
Tenaris
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network